Can You Stay on the Lowest Dose of Mounjaro Long-Term?

What is the 2.5 mg dose actually for?

Mounjaro's licensed titration schedule starts at 2.5 mg for the first four weeks. The Mounjaro SmPC on the eMC is clear on this point: 2.5 mg is not a therapeutic dose for weight management. It exists so your digestive system can adapt to tirzepatide gradually, reducing the nausea, vomiting and other gastrointestinal effects that are more common when treatment starts. Think of it as an acclimatisation period rather than active treatment.

After four weeks, the standard schedule moves to 5 mg, then typically in further 4-week steps up to the highest tolerated dose. The clinical trials that generated Mounjaro's weight-loss evidence, including SURMOUNT-1, used doses of 5 mg, 10 mg and 15 mg. At 15 mg, participants lost around 20–21% of body weight on average over 72 weeks. The 2.5 mg group was not evaluated as a long-term maintenance arm because that was never its design intention.

This does not mean your prescriber cannot slow things down. It means that if you want to discuss staying at the lowest Mounjaro dose for longer, that conversation should happen with a clinician who can weigh up the reasons and document the decision properly.

Can a prescriber agree to keep you at a lower dose than normal?

Yes, within clinical judgement. Prescribers are not obligated to push every patient to 15 mg. If you are losing weight steadily, tolerating treatment well and your prescriber judges the current dose to be sufficient for your health goals, staying lower is a legitimate clinical choice. Some people find that 5 mg delivers enough appetite regulation for their needs without the side-effect burden some experience at higher strengths.

What a prescriber will want to see before agreeing to stay at a low dose long-term is evidence that it is actually working: meaningful weight loss, maintained consistently, with no signs of plateau. If weight loss has stalled and the dose has not moved up, that is a different conversation.

The 2.5 mg dose specifically is harder to justify as a permanent maintenance level, because the licensed indications and trial data are built around higher doses. A prescriber keeping you there would need clear clinical reasoning. If you have concerns about tolerability at higher doses, those concerns are worth raising directly, and our guide to the lowest dose of tirzepatide covers what the evidence says about staying lower for longer. You can read more on the frequently asked questions page or speak to the team via our support line.

What if you genuinely cannot tolerate moving up?

Tolerability is a real clinical concern, not a minor detail. Some people experience persistent nausea or gastrointestinal discomfort that makes dose increases very difficult. In those cases, a prescriber may extend the time at the current dose before attempting the next step, or they may consider whether Mounjaro is the right treatment for you at all.

The NHS patient information for tirzepatide notes that nausea and other GI symptoms are among the most commonly reported effects, particularly early in treatment or after a dose increase, and that they often settle over time. This matters, because many people feel most uncomfortable in the first few weeks at a new dose and then find the symptoms ease considerably.

Practical things that can help: keeping meals smaller, avoiding rich or fatty food especially around injection day, and staying hydrated. Some people find slotting the injection into a consistent weekly routine, like keeping the pen in the fridge door alongside regular weekly shopping, helps them stay organised and notice patterns in how they feel. If symptoms do not ease after a reasonable settling-in period, tell your prescriber rather than quietly staying at a dose that may not be serving you well.

For a wider look at whether 2.5 mg specifically is an option long-term, or to understand how the full titration journey tends to work in practice, our dosage guidance pages cover both in detail. The Mounjaro overview is a good starting point if you are still building your understanding of the treatment as a whole.

How does this affect cost, and what should you do next?

One practical note for anyone thinking about staying at a lower dose for financial reasons: the price of private Mounjaro treatment in the UK varies by dose and provider. The Mounjaro price comparison page sets out the market context honestly, including how Eli Lilly's list price changes in 2025 affected what pharmacies charge at different dose levels. That information is worth reading before making any clinical decisions based on cost alone, because choosing a dose primarily to save money is a reason your prescriber will want to explore with you.

The right dose is the one your prescriber recommends based on your response and tolerability, not the lowest one that happens to be cheaper. At the same time, a clinical reason to stay lower is entirely valid, and a good prescriber will support that decision if the evidence supports it.

If you want a clear, same-day clinical review from a real prescriber, not an automated questionnaire, check your eligibility with our team and start the conversation properly.